Other Assets, Current of ImmunityBio, Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
ImmunityBio, Inc. quarterly Other Assets, Current in USD history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • ImmunityBio, Inc. Other Assets, Current for the quarter ending 30 Sep 2025 was $2,513,000, a 84% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

ImmunityBio, Inc. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,513,000 +$1,146,000 +84% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,642,000 +$1,162,000 +242% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $2,353,000 -$222,000 -8.6% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,303,000 -$235,000 -15% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $1,367,000 -$3,017,000 -69% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $480,000 -$4,074,000 -89% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $2,575,000 -$1,853,000 -42% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $1,538,000 -$441,000 -22% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $4,384,000 +$1,148,000 +35% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $4,554,000 +$1,555,000 +52% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $4,428,000 +$445,000 +11% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,979,000 -$978,000 -33% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $3,236,000 +$2,981,000 +1169% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $2,999,000 +$2,716,000 +960% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $3,983,000 +$3,645,000 +1078% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $2,957,000 +$2,847,000 +2588% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $255,000 +$165,000 +183% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $283,000 +$216,000 +322% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $338,000 +$260,000 +333% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $110,000 -$567,000 -84% 31 Dec 2020 10-Q 12 Nov 2021 2021 Q3
Q3 2020 $90,000 +$42,000 +88% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $67,000 +$16,000 +31% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $78,000 -$2,000 -2.5% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $677,000 +$635,000 +1512% 31 Dec 2019 8-K/A 22 Apr 2021
Q3 2019 $48,000 -$155,000 -76% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $51,000 -$212,000 -81% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $80,000 -$248,000 -76% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $42,000 -$233,000 -85% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q3 2018 $203,000 -$83,000 -29% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $263,000 -$39,000 -13% 30 Jun 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 $328,000 +$86,000 +36% 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 $275,000 $0 0% 31 Dec 2017 10-K 13 Mar 2019 2018 FY
Q3 2017 $286,000 +$34,000 +13% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $302,000 +$291,000 +2645% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $242,000 +$52,000 +27% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 $275,000 +$275,000 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 $252,000 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 $11,000 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 $190,000 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $0 31 Dec 2015 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.